Navigation Links
Delcath Systems Receives Preliminary Notification of Inclusion in Russell 3000(R) Index
Date:6/15/2009

NEW YORK, June 15 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it will be added to the broad-market Russell 3000(R) Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 26, 2009. According to the preliminary list of additions posted June 12, 2009 on www.russell.com, selection to the Russell 3000(R) Index means Delcath is automatically included in the popular Russell 2000(R) Index, which measures the performance of approximately 2,000 small-cap U.S. securities.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO )

About Russell:

Russell Investments provides strategic advice, world-class implementation, state-of-the-art performance benchmarks and a range of institutional-quality investment products. Russell has $136 billion in assets under management as of March 31, 2009, and serves individual, institutional and advisor clients in more than 40 countries. Founded in 1936, Russell is a subsidiary of The Northwestern Mutual Life Insurance Company.

About Delcath Systems, Inc.:

Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of liver cancers. Delcath's novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer drugs to the liver while preventing these high doses of drug from enter
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Delcath Enters Agreement to Sell 869,565 Units
2. Delcath Systems Granted Third Orphan Drug Designation
3. Eric D. Whitman, MD to Present on the Delcath PHP System(TM) at the 7th World Congress on Melanoma
4. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Reaches Halfway Point
5. Delcath Adds Senior Pharmaceutical Professional to Its Board of Directors
6. Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors
7. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
8. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
9. Penguin Computing Forms OEM Agreement with Applied Biosystems for Scyld ClusterWare
10. SANYO Donates Air Purification Systems Effective Against Flu Viruses to New York Airports and Schools
11. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 The global consumption of squalene / ... is a natural skin-identical chemical that finds applications in various ... supplements, pharmaceuticals, and in other applications like high grade lubrication, ... a few major players and is regionally segregated. Sophim ( ... Oil Co. Ltd. ( Japan ), SeaDragon Marine ...
(Date:9/17/2014)... 2014  MiMedx Group, Inc. (NASDAQ: ... of patent protected regenerative biomaterials and bioimplants processed ... another peer-reviewed clinical study.    The ... Controlled Clinical Trial Evaluating the Use of ... Multi-layer Compression Therapy vs. Multi-layer Compression Therapy Alone ...
(Date:9/17/2014)... Terracon Corporation has announced the introduction of ... This addition to the company’s industry-leading line of ... and available in 125 or 250 gallon capacities. ... weeks or less. , The new pre-engineered TerraPure tank ... existing TerraPure tank line – plus quick turnaround. ...
(Date:9/17/2014)... FRANCISCO, Calif. , Sept. 17, 2014 ... a molecular diagnostics company pioneering the field of molecular ... to chief operating officer. Mr. Hall joined ... the company,s commercial entry into endocrinology. Since 2012, he ... as well as managed care and billing functions. As ...
Breaking Biology Technology:Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 2MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 3MiMedx Multi-Center Randomized, Controlled VLU Clinical Study Published In Peer-Reviewed Journal 4Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 2Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 3Veracyte, Inc. Announces Promotion of Christopher M. Hall To Chief Operating Officer 4
... Owner of PHC Consulting) hasn't felt a down economy at all. ... in the medical industry (laboratory clinical and research, physician call points, ... for revenues and Peggy attributes that growth to a strong web ... ...
... PALO ALTO, Calif., June 25 Cell Biosciences, ... systems,to life science researchers, today announced three important ... named President and Chief Executive Officer. From 1998,through ... for Molecular,Devices Corporation where he helped build the ...
... U.S. Food and Drug,Administration (FDA) Advisory Committee ... the approval of tolvaptan, Otsuka Pharmaceutical,Development & ... hyponatremia., "Otsuka is pleased that the ... tolvaptan, an investigational selective,V2-vasopressin receptor antagonist," said ...
Cached Biology Technology:Website and Blog Increase Placement for Medical Sales Recruiter - Providing Sales Winners Calling on the Hospital, Lab and Physician Call Point 2Cell Biosciences Announces New Leadership 2U.S. Food and Drug Administration Advisory Committee Recommends Approval of Tolvaptan, an Investigational Treatment for Hyponatremia 2
(Date:9/17/2014)... BELLINGHAM, Washington, USA -- "Nature has developed, very cleverly, ... we desire in optical design," said Joseph Shaw, director ... "As we explore surfaces and structures at the nanoscale, ... presented in San Diego in August during a conference ... by Shaw and Rongguang Liang of the University of ...
(Date:9/17/2014)... (Hospital del Mar Medical Research Institute) and at the ... study in eLife showing that RNA called ... of new proteins, some of which could have important ... from the instructions found in an RNA molecule. However, ... information for the synthesis of proteins, meaning it is ...
(Date:9/17/2014)... retinoblastoma protein gene are a leading cause of eye ... fruit fly eyes to unlock the secrets of this ... on the cover of the current issue of the ... researchers provide the first detailed examination of a set ... cancer gene, said Irina Pushel, MSU undergraduate and co-author. ...
Breaking Biology News(10 mins):Nature's designs inspire research into new light-based technologies 2Nature's designs inspire research into new light-based technologies 3Parts of genome without a known function may play a key role in the birth of new proteins 2Abnormal properties of cancer protein revealed in fly eyes 2
... Farmers who don,t rely on or want to minimize the ... battle against aggressive perennial weeds. In ongoing research at the ... be a worthy contender as a summer smother crop. ... The Sudangrass creates shade so photosynthesis cannot occur in the ...
... WEST LAFAYETTE, Ind. - Wheat plants found to ... in reinforcements to build up rigid defenses. Christie ... Agriculture,s Agricultural Research Service and a Purdue University associate ... by Hessian fly larvae increased production of surface waxes ...
... Bringing the power of synchrotron light to Minnesota,s ... of a Memorandum of Agreement (MOA) signed today between ... synchrotron facility, the Canadian Light Source (CLS). ... and product outcomes while improving operating efficiency for both ...
Cached Biology News:Sudangrass recommended to combat Canada thistle 2Sudangrass recommended to combat Canada thistle 3Resistant wheat rebuilds cell walls when attacked by Hessian flies 2BioBusiness Alliance, Canadian Light Source Synchrotron sign agreement 2